drugset / Trial / NCT01126177

Comparing Efficacy and Safety of Inhaled SNG001 to Placebo

NCT01126177

Phase 2 Completed 300 enrolled Synairgen Research Ltd.
RandomizedParallel-groupQuadruple-blindTreatment

Summary

When people with asthma get respiratory virus such as a cold or flu it often increases asthma symptoms. The investigators will test the study medication to find out if it can prevent the virus spreading from the nose to the lungs. SNG001 contains Interferon-beta that occurs naturally in the body. In this study, SNG001 will be given by a nebuliser.

Timeline

Start
2010-03
Primary completion
2011-10
Completion
2012-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Interferon beta-1a Protein / enzyme biologic Inhaled

Indications